- Home
- Peptide Guides
- Peptides for Migraine Prevention
Peptides for Migraine Prevention
Last updated: 2026-03-27
Migraine affects approximately 10 million people in the UK and is the third most common disease globally. While recent CGRP-targeting monoclonal antibodies (erenumab, fremanezumab, galcanezumab) have transformed migraine prevention, interest exists in whether other peptide-based approaches could complement existing treatments.
Calcitonin Gene-Related Peptide (CGRP) itself is a 37-amino-acid neuropeptide that plays a central role in migraine pathophysiology. The success of anti-CGRP treatments validates the peptide-based approach to migraine and has opened research into other neuropeptide targets.
BPC-157 has shown neuroprotective and anti-inflammatory effects in preclinical studies that may be relevant to the neuroinflammatory component of migraine. Selank, with its anxiolytic and neuroprotective properties, is researched for conditions with neurological and stress-related components.
All information is educational. Migraine should be managed per NICE CG150/NG217 under GP or neurologist guidance.
What this guide is — and what to do first
Peptide research for this condition is interesting, but it is not the first thing to consider. The blocks below cover standard UK care, when to see your GP, what licensed treatments exist, and how the peptide evidence actually stacks up.
Standard care first
NICE NG217 (headaches) and CG150 (migraine) frame UK migraine care. Acute attack: triptans (sumatriptan first-line) + NSAID / paracetamol; antiemetic for nausea. Preventive treatment if ≥4 migraines/month or significant disability: propranolol or topiramate first-line; amitriptyline, candesartan, sodium valproate (not in childbearing women) as alternatives; CGRP monoclonal antibodies (NICE-approved) after 3+ preventive failures. Lifestyle: identify and manage triggers (sleep, hydration, regular meals, caffeine consistency, stress management). Avoid medication-overuse headache from frequent acute treatment.
When to speak to your GP
See your GP if migraines are frequent (≥4 per month), severe enough to disrupt work or daily life, not responding to OTC analgesia, or if pattern is changing. Urgent same-day assessment for: sudden-onset 'thunderclap' headache (possible SAH), headache with fever / neck stiffness (possible meningitis), headache with focal neurological signs, headache after head injury, headache with vision changes / weakness. Specialist neurology / headache-clinic referral for chronic migraine or treatment-refractory cases.
UK-approved treatments for this condition
Acute: triptans (sumatriptan, rizatriptan, zolmitriptan), NSAIDs, paracetamol, antiemetics. Preventive: propranolol, topiramate, amitriptyline, candesartan, sodium valproate, flunarizine. CGRP monoclonal antibodies — erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), eptinezumab — NICE-approved for chronic migraine after 3+ preventive failures. Atogepant / rimegepant — small-molecule CGRP receptor antagonists, expanding NICE access. Botulinum toxin A for chronic migraine per NICE TA260. CGRP-pathway drugs are the only peptide-based MHRA-licensed migraine treatments.
What the peptide evidence actually says
| Peptide | Human evidence | UK status | Honest verdict |
|---|---|---|---|
| Anti-CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) | Strong (multiple Phase 3 RCTs) | Licensed POM; NICE-approved | The peptide-pathway-based treatment that works. Available via NHS headache clinics for eligible patients. |
| BPC-157 | None for migraine | Unlicensed | Mechanistically interesting; no human migraine trial. |
| Selank / Semax | Russian-licensed for other CNS indications; no migraine data | Unlicensed in UK | Not validated for migraine treatment. |
How Peptides May Help
CGRP is released from trigeminal nerve endings during migraine attacks, causing vasodilation of meningeal blood vessels and neurogenic inflammation. Anti-CGRP monoclonal antibodies (already NICE-approved) block this peptide's action, preventing migraines. This demonstrates that peptide pathways are central to migraine biology.
BPC-157 has shown effects on multiple neurotransmitter systems (dopamine, serotonin, GABA) in preclinical research, and its anti-inflammatory properties may be relevant to the neuroinflammatory cascade in migraine. However, no human migraine-specific studies exist.
Selank's modulation of GABA-ergic pathways and its anxiolytic effects may be relevant given the strong association between anxiety, stress, and migraine frequency. Stress is one of the most commonly reported migraine triggers.
Researched Peptides
BPC-157
Moderate
Neuroprotective and anti-inflammatory properties; modulates multiple neurotransmitter systems in preclinical studies
Selank
Low
Anxiolytic neuropeptide; may address stress-triggered migraines through GABA modulation
Semax
Low
ACTH analogue with neuroprotective research; may support neurological resilience
Peptide Comparisons
Anti-CGRP monoclonal antibodies (erenumab, fremanezumab) are the proven peptide-based migraine treatments, now NICE-approved and available on NHS. Research peptides like BPC-157 and Selank have theoretical relevance but no clinical evidence for migraine specifically.
Safety Considerations
Anti-CGRP treatments are the only peptide-based approaches with proven efficacy for migraine prevention. Research peptides should not be used as alternatives to evidence-based migraine treatments including triptans (acute), beta-blockers, topiramate, or anti-CGRP antibodies (preventive).
Migraine is a complex neurological condition that may indicate other underlying issues. Patients with new-onset migraine, change in migraine pattern, or migraine with aura should seek proper neurological assessment.
Frequently Asked Questions
Conclusion
The success of anti-CGRP monoclonal antibodies demonstrates that peptide-based approaches to migraine are scientifically valid and clinically effective. These treatments are now available on the NHS for chronic migraine. Research peptides like BPC-157 and Selank have theoretical relevance but no clinical migraine evidence. Migraine management should follow NICE CG150/NG217 guidelines.
*This information is for educational purposes only. Migraine requires proper diagnosis and management. Refer to NICE CG150 for acute migraine and NG217 for headache guidance.*
Medical Disclaimer
The information provided on this page is for educational and research purposes only. The peptides discussed are not approved medications for the conditions described. This content does not constitute medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement.
Related Categories
Explore Other Guides
Peptides for Tendon Injuries & Repair
Tendon injuries—whether from sports, repetitive strain, or age-related degeneration—represent some of the most challengi...
Peptides for Fat Loss & Weight Management
The search for effective weight management solutions has led researchers to investigate various peptides that may influe...
Peptides for Muscle Growth & Recovery
The pursuit of enhanced muscle growth, improved recovery, and optimised body composition has driven significant interest...
Peptides for Anti-Ageing & Longevity
The science of ageing has advanced dramatically, moving from inevitable decline to a potentially modifiable process. Pep...
Peptides for Cognitive Enhancement & Brain Health
Cognitive enhancement—improving memory, focus, mental clarity, and brain health—has become a major area of interest in p...
Peptides for Immune Support & Function
The immune system's complexity and critical role in health has made it a major focus of peptide research. From thymic pe...
Peptides for Sexual Health & Function
Sexual health encompasses physical function, desire, satisfaction, and psychological wellbeing—all influenced by complex...
Peptides for Joint Health & Cartilage Repair
Joint health issues—including osteoarthritis, cartilage degeneration, and chronic joint pain—affect millions of people w...
Peptides for Sleep Optimization & Sleep Quality
Sleep is fundamental to health, affecting everything from cognitive function and immune defence to metabolic regulation ...
Peptides for Blood Sugar Management & Glycaemic Control
Blood sugar dysregulation affects hundreds of millions of people globally. Type 2 diabetes alone impacts over 530 millio...
Peptides for Anxiety & Stress Reduction
Anxiety and chronic stress affect millions of people worldwide and represent a growing area of unmet clinical need. Whil...
Peptides for Athletic Performance & Recovery
The intersection of peptide science and sports performance has become one of the most actively researched — and debated ...
Peptides for Heart Health & Cardiovascular Support
Cardiovascular disease remains the leading cause of death worldwide, accounting for approximately 17.9 million deaths an...
Peptides for Liver Health & Detoxification
The liver is the body's primary metabolic and detoxification organ, responsible for over 500 essential functions includi...
Peptides for Autoimmune Conditions & Immune Modulation
Autoimmune diseases — conditions in which the immune system mistakenly attacks the body's own tissues — affect approxima...
Peptides for Post-Surgery Recovery & Wound Healing
Post-surgical recovery is a complex physiological process involving haemostasis, inflammation, proliferation, and remode...
Peptides for Skin Pigmentation & Tanning
Skin pigmentation is primarily determined by the production and distribution of melanin — a family of pigments synthesis...
Peptides for Fertility & Reproductive Health
Fertility and reproductive health are regulated by an intricate hormonal network centred on the hypothalamic-pituitary-g...
Peptides for Weight Loss
Weight loss has become one of the most significant public health priorities in the United Kingdom. According to NHS Engl...
Peptides for Diabetes & Blood Sugar Control
Type 2 diabetes is one of the most significant health challenges facing the United Kingdom. Diabetes UK estimates that a...
Peptides for Bodybuilding & Muscle Gain
Bodybuilding and strength sports have long driven interest in compounds that may enhance muscle growth, accelerate recov...
Peptides for Knee Pain & Joint Support
Knee pain is one of the most prevalent musculoskeletal complaints worldwide, affecting an estimated 25% of adults and ac...
Peptides for Back Pain & Spinal Health
Back pain is the leading cause of disability worldwide and one of the most common reasons for GP consultations in the Un...
Peptides for IBS & Digestive Disorders
Irritable bowel syndrome (IBS) affects an estimated 10-15% of the UK population and is the most common functional gastro...
Peptides for Depression & Mood Support
Depression is one of the most prevalent mental health conditions globally, affecting an estimated 5% of the adult popula...
Peptides for PCOS (Polycystic Ovary Syndrome)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, with an esti...
Peptides for Chronic Fatigue & CFS/ME
Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) or ME/CFS, is a complex, debilitating condi...
Peptides for Neuropathy & Nerve Health
Neuropathy — damage or dysfunction of peripheral nerves — affects an estimated 2-3% of the general population, with prev...
Peptides for Thyroid Health & Function
Thyroid disorders are among the most common endocrine conditions in the United Kingdom, affecting an estimated 2-5% of t...
Peptides for Respiratory & Lung Health
Respiratory disease is the third leading cause of death in the United Kingdom, with chronic obstructive pulmonary diseas...
Peptides for Long COVID & Post-Viral Syndrome
Long COVID — formally known as post-COVID-19 syndrome — affects an estimated 1.9 million people in the UK (ONS, 2024). D...
Peptides for Fibromyalgia & Chronic Pain
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and co...
Peptides for Lyme Disease & Post-Treatment Syndrome
Lyme disease, caused by the spirochaete bacterium *Borrelia burgdorferi* (and related species *B. garinii* and *B. afzel...
Peptides for Erectile Dysfunction & Sexual Performance
Erectile dysfunction (ED) affects an estimated 4.3 million men in the UK, with prevalence increasing significantly after...
Peptides for Infertility: Male & Female Fertility Research
Infertility affects approximately 1 in 7 couples in the UK, with roughly equal contributions from male and female factor...
Peptides for Osteoarthritis & Joint Health
Osteoarthritis (OA) affects over 10 million people in the UK and is the most common form of arthritis, characterised by ...
Peptides for Menopause: Hot Flashes, Bone Loss, Skin & Mood
Menopause affects every woman, typically occurring between ages 45-55 in the UK, with an average age of 51. The decline ...
Peptides for Neuropathic Pain & Nerve Damage
Neuropathic pain — caused by damage or dysfunction of the nervous system itself — affects approximately 7-8% of the UK p...
Peptides for Disc Degeneration & Back Pain
Intervertebral disc degeneration is the most common cause of chronic lower back pain, affecting an estimated 80% of adul...
Peptides for Frozen Shoulder Recovery
Frozen shoulder (adhesive capsulitis) affects 2-5% of the general population and up to 20% of people with diabetes. It c...
Peptides for Bone Density & Osteoporosis Prevention
Osteoporosis affects approximately 3.5 million people in the UK, causing over 500,000 fragility fractures annually. The ...
Peptides for Cardiovascular Health & Heart Protection
Cardiovascular disease (CVD) remains the UK's leading cause of death, accounting for approximately 160,000 deaths annual...
Peptides for Thyroid Function & Support
Thyroid disorders affect approximately 2-5% of the UK population, with hypothyroidism being far more common than hyperth...
Musculoskeletal Recovery — peptide research hub
Peptide research that touches the musculoskeletal system spans tendon and ligament repair, joint inflammation, cartilage...
Metabolic and Weight — peptide research hub
The metabolic-and-weight space is the most heavily-licensed corner of peptide medicine in the UK — semaglutide (Wegovy /...
Neuro and Mood — peptide research hub
Neuropeptide research is dominated by compounds developed in Russia and Eastern Europe with decades of regional clinical...
Immune and Inflammation — peptide research hub
Immune-modulating and anti-inflammatory peptides are an active research area with thin human-trial data for the conditio...
Skin and Aesthetics — peptide research hub
Cosmetic peptide use splits into two very different categories: topical peptides (GHK-Cu, Matrixyl, Argireline, SNAP-8) ...
Hormonal and Reproductive — peptide research hub
Hormonal and reproductive-health peptides span fertility hormones (gonadorelin, GnRH analogues), menopause-related resea...
Peptides for Hair Growth & Follicle Health
Hair loss affects millions of people worldwide, with androgenetic alopecia (pattern baldness), telogen effluvium, and al...
Peptides for Skin Health & Anti-Ageing
Peptides have revolutionised modern skincare, offering science-backed approaches to anti-ageing, wound healing, and skin...
Peptides for Gut Health & Digestive Repair
Gastrointestinal health is fundamental to overall wellbeing, influencing everything from nutrient absorption and immune ...
Peptides for Wrinkle Reduction & Skin Rejuvenation
Cosmetic peptides have revolutionised the skincare industry, offering targeted mechanisms for addressing different types...
Peptides for Skin Firmness & Collagen Restoration
Skin firmness depends fundamentally on the dermal extracellular matrix—a dense network of collagen, elastin, and glycosa...
Peptides for Wound Healing & Tissue Repair
Wound healing is a complex, multi-phase biological process involving inflammation, proliferation, and remodelling. Chron...
Peptides for Inflammation & Immune Modulation
Chronic inflammation underlies many of the most prevalent health conditions—from autoimmune disorders and cardiovascular...
Peptides for Bone Health & Fracture Recovery
Bone health is a critical concern across the lifespan—from fracture healing in athletes and trauma patients to osteoporo...
Peptides for Anxiety & Stress Management
Anxiety disorders are among the most prevalent mental health conditions globally, affecting approximately 284 million pe...
Peptides for Energy & Metabolic Optimisation
Energy metabolism—the complex system by which cells convert nutrients into usable energy—underlies virtually every aspec...